authors
- Meredith, PA
- Ostergren, J
- McMurray, JJV
- Granger, CB
- Swedberg, K
- Yusuf, Salim
- Michelson, EL
- Olofsson, B
- Puu, M
- Solomon, SD
- Pfeffer, MA
Benefits of candesartan are consistent regardless of pre-treatment systolic blood pressure in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- March 6, 2007
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)